切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Inward Rectifier Potassium (Kir) Channels - SMARCA4 - Hck - p70 rsk

12件产品中的 1-10

页面
每页
清除全部
  1. LY2584702
    B5815 LY2584702
    Target: p70 rsk
    Summary: P70 S6激酶抑制剂
      ≥22.25 mg/mL
      insoluble in H2O
  2. PFI 3
    B7744 PFI 3
    Target: Protein polybromo-1|SMARCA4|SMARCA2
    Summary: Polybromo 1和SMARCA4抑制剂
      ≥15.15 mg/mL
      insoluble in H2O
  3. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  4. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  5. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  6. PF-4708671
    B2228 PF-4708671
     1 Citation
    Target: p70 rsk
    Summary: P70 S6K1亚型抑制剂
      ≥37.8 mg/mL
      insoluble in H2O
  7. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  8. PP121
    B2172 PP121
    Target: mTOR|Eph Receptors|VEGFR|PDGFR|Bcr-Abl|Src|DNA-PK|P110|Hck
    Summary: 酪氨酸激酶和磷酸肌醇激酶双重抑制剂
      ≥15.95 mg/mL
      insoluble in H2O
  9. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  10. AT7867
    A5653 AT7867
    Target: Akt|PKA|p70 rsk
    Summary: Akt1/2/3和p70S6K/PKA的抑制剂
      ≥16.9 mg/mL
      ≥45 mg/mL

12件产品中的 1-10

页面
每页